Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
Icona Anti-Diabetic

1.0 by Newthoughts dev


Sep 1, 2017

Informazioni su Anti-Diabetic

AN APPLICATION ON ANTI-DIABETICS

APPLICATION PROVIDE KEY NOTES ON ANTI-DIABETICS

NewThoughts Developer will try to help you by providing android application on important key notes for the preparation of GPAT and various National level entrance examination exam.

Key notes would also useful for the preparation of B. Pharmacy and M. Pharmacy examination as well as for various National level examination.

M.Pharma is one of the most important degree to get higher posts in pharmaceutical industry. GPAT qualified candidates not only have advantage to receive scholarship over M.Pharm admission but have chances of placement in best companies of the world in the best pay scale.

* GPAT qualifiers are also eligible for NIPER-JEE.

* GPAT qualified candidates are also eligible for various government fellowships.

* GPAT qualified candidates are eligible for admission in Ph.D at various universities of India?

Key Words; GPAT, B. PHARMACY, M. PHARMACY,

Novità nell'ultima versione 1.0

Last updated on Sep 1, 2017

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Traduzione in caricamento...

Informazioni APP aggiuntive

Ultima versione

Richiedi aggiornamento Anti-Diabetic 1.0

È necessario Android

2.3 and up

Available on

Ottieni Anti-Diabetic su Google Play

Mostra Altro

Anti-Diabetic Screenshot

Commento Loading...
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Abbonato con successo!
Ora sei iscritto ad APKPure.
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Successo!
Ora sei iscritto alla nostra newsletter.